Skip to content

Your FDA question.Every source.An answer with receipts.

Ask about drugs, devices, trials, inspections, and enforcement in plain English, then open the record behind every claim.

Sweeps openFDA, FAERS, MAUDE, ClinicalTrials.gov, inspections, and warning lettersAsk

Example questions: What are the most reported adverse events for GLP-1 agonists? Show me Class I device recalls from the past 6 months Find Phase 3 oncology trials recruiting in the US Find warning letters mentioning 21 CFR Part 11 Compare Eli Lilly and Novo Nordisk diabetes trials When were Rezdiffra, Kisunla, and Cobenfy first approved?

Your first 3 standard queries are free. Pro is $40/month.

Used by professionals at

  • Pfizer
  • Moderna
  • Medtronic
  • Madrigal
  • Novartis
  • Amgen
  • Neuralink
  • Boston Scientific
  • Nuvalent
  • AstraZeneca
  • Regeneron
  • Abbott
  • Revolution Medicines
  • Synchron
  • Merck
  • Gilead
  • Stryker
  • Insmed
  • Roche
  • Vertex
  • Precision Neuroscience
  • Becton Dickinson
  • Recursion
  • Eli Lilly
  • Beam Therapeutics
  • NeuroPace

Watch the agent work.

The chat carries the conversation. The canvas beside it holds the evidence. Every question moves through the same four stages.

  1. Question

  2. Sweep

  3. Canvas

  4. Brief

FDAgent

What are the most reported adverse events for GLP-1 agonists?

Define the drugs included in the classPending
Search reports for the selected drugsPending
Read warnings and precautionsPending
Group reported reaction terms by countPending
Note reporting limits and uncertaintyPending
Arrange the results in a tablePending
Summarize with source links for reviewPending

Illustrative run · real FAERS counts

Insights Canvas

Visualizations & analysis

Insights canvas

Charts, tables, and AI analysis appear here as you query FDA data

Charts
Tables
Insights

12+ FDA databases • Export to Excel, CSV, JSON

117,000+
Inspections
125,000+
Form 483 observations
1,400+
Warning letters, full text
12+
FDA databases

Inspections, Form 483s, warning letters, and establishment registrations refresh every day from FDA sources. Orange Book listings refresh monthly. Every record shows its source and when it was last checked.

Built for the work regulatory and quality teams actually do.

Regulatory affairs, quality and compliance, business development, and the consultants who support them. Every answer links to the record, and every benchmark states its sample size.

Qualify a supplier before an audit

Inspection history, Form 483 observations, and warning letters for a facility, benchmarked against its product-type peers.

Prepare for an inspection

The citation patterns investigators are writing up for firms like yours, with the CFR references and sample sizes shown.

Track a competitor’s regulatory record

Approvals, recalls, enforcement, and trial pipelines in one thread, with watches when something changes.

Brief leadership on a recall or warning letter

A sourced compliance brief you can share as a read-only link the same afternoon.

Walk away with a brief.

Not a chat transcript. A print-ready compliance brief with inspection history, citation patterns, peer benchmarks, and a link your team can open. The agent does the sweeping. You get the document.

A question is just the beginning.

Research across the FDA record. Explore the evidence, ask a follow-up, and keep following what matters.

Live Agent Research

Follow the agent’s searches and evidence checks as your research unfolds.

Insights Canvas

Explore linked tables, charts, and source records. Export to Excel, CSV, or JSON.

Deep Research

Investigate across sources, follow evidence gaps, and keep a structured research report.

Drug, Device & Trial Data

Connect approvals, safety reports, devices, and trial pipelines in one conversation.

Portfolios

Track suppliers or competitors together, with inspection history, risk rankings, and trends.

Full-Spectrum Alerts

Follow inspections, warning letters, recalls, and approvals across the firms you watch.

Peer Benchmarks & CFR Scorecards

Compare inspection outcomes and citation patterns with peers, with sample sizes shown.

Compliance Briefs

Turn facility, company, or portfolio research into a printable brief with a shareable link.

Private by default.

Your questions, cases, and briefs are visible only to you and the teammates you share them with. Encrypted in transit and at rest. Zero data retention and SSO on Company plans. Talk to us.

Choose your plan.

Ask an FDA question, follow the agent’s research, and inspect the evidence behind its answer.

Pro

$40 / month

For individual regulatory research.

  • Unlimited standard queries
  • 10 Deep Research runs per day
  • Portfolios, watches, and compliance briefs
View Pro

Team

$249 / month

For teams researching FDA data together.

  • Everything in Pro for each member
  • 5 seats, including the owner
  • 10 Deep Research runs per day, per member
  • Shared cases with editor and viewer permissions
  • One subscription with centralized billing
Set up your team

Deep Research is separate from standard queries. Each member’s daily allowance is shared across their personal and team work. Price and allowances are confirmed at checkout.

3 queries free

Try standard queries with real FDA records.

Start free

Company

Zero data retention and SSO available. Talk with us about your organization.

Contact us

Explore one example workflow: Sample supplier review · Fictional data, no signup or query credits needed.

Bring your next FDA question.

Follow the agent’s research, inspect the sources, and see where the next question takes you.

Your first 3 standard queries are free. Pro is $40/month.